Physician profile
Jonathan Benjamin Macknin
NPI 1740442730
$1,785.44
in general payments reported to CMS, 2019-2025
10 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $951 · 2022: $18.46 · 2023: $119 · 2024: $41.47 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $916.13 | 2020 | |
| Stryker Corporation | $390.12 | 2019-2025 | Variax, Conextions Tr Tendon Repair System-Implant Mechanism, Dart-Fire |
| Boston Scientific Corporation | $136.67 | 2025 | General - Pain Management |
| Davol INC. | $118.89 | 2023 | Arista Ah Flexitip |
| Arteriocyte Medical Systems, INC. | $83.31 | 2019 | |
| Ethicon US, LLC | $41.47 | 2024 | Dermabond |
| Depuy Synthes Sales INC. | $35.64 | 2025 | Va-Lcp |
| Zimmer Biomet Holdings, INC. | $32.47 | 2019 | |
| Acumed LLC | $16.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Macknin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.